Filing Details

Accession Number:
0001288123-17-000038
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-10-31 10:08:56
Reporting Period:
2017-10-27
Accepted Time:
2017-10-31 10:08:56
Original Submission Date:
2017-10-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098972 Agenus Inc AGEN () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
935679 H Garo Armen 3 Forbes Road
Lexington MA 02421
Chairman & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-10-27 59,612 $3.51 1,550,053 No 4 P Direct
Common Stock Acquisiton 2017-10-30 40,388 $3.61 1,590,441 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,046 Indirect by Antigenics Holdings
Footnotes
  1. Dr. Armen is Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.